Neurotech solutions is a digital health company focused on eliminating undiagnosed ADHD. The companys mission is to help every person with ADHD lead a better life and fulfill their potential.
Neurotech Solutions core technology is a cloud-based, AI-driven online test that looks and feels like a game. The technology was first implemented in a clinical product called MOXO d-CPT, a decision-support tool for the diagnosis of ADHD.
Using MOXO d-CPT, a healthcare professional can obtain objective, standardized, comparative results about a patients attentional difficulties in just 14 to 18 minutes. More than 500,000 MOXO tests have been performed to date in over 20 countries. During the COVID-19 pandemic, the company released a home version of MOXO to enable a full remote and objective diagnosis of ADHD.
The companys core technology was also implemented in an educational product called AXON-School. Intended for all K-12 children, the product objectively highlights children with attentional difficulties and suggests educational strategies for personalized learning.
Neurotech Solutions opened a subsidiary in Guangzhou, China, in 2021.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Neurotech Solutions Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jul 9, 2020
cordis.europa.eu
Mobile device for ADHD diagnosis and support MOXO-Mobile Phase-1 Project Results in brief H2020 CORDIS European Commission
undefined
Mar 14, 2018
www.linkedin.com
Neurotech-Solutions Secures $3.5 Million to Fuel Aggressive Growth of its ADHD screening and diagnosis business in China.